Related Experiment Video
Updated: Mar 13, 2026

Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
Metabolic risk factors in pediatric stone formers: a report from an emerging economy
Kiran Imran1, Mirza Naqi Zafar2, Uzma Ozair2
1Department of Chemical Pathology, Sindh Institute of Urology and Transplantation, Karachi, Pakistan. kiranimran10@gmail.com.
Insights
This study identified metabolic risk factors in 98% of pediatric stone formers, highlighting the importance of early detection and metaphylaxis for preventing kidney stones in children.
Area of Science:
- Pediatric Nephrology
- Metabolic Disorders
- Urolithiasis Research
Background:
- Pediatric kidney stone disease is a growing concern, particularly in emerging economies.
- Identifying metabolic risk factors is crucial for effective management and prevention of recurrent stone formation in children.
Purpose of the Study:
- To investigate the prevalence and types of metabolic risk factors in pediatric stone formers in an emerging economy.
- To analyze these risk factors by gender and age groups (<1-5, 6-10, and 11-15 years).
Main Methods:
- Prospective enrollment of 250 pediatric patients (age <1-15 years) with kidney stones.
- Evaluation of demographic data, blood tests, and 24-hour urine analysis for various metabolic parameters (calcium, magnesium, phosphate, uric acid, citrate, oxalate, etc.).
- Statistical analysis to determine significance (p ≤0.05) and compare risk factors across genders and age groups.
Main Results:
- Urinary metabolic abnormalities were identified in 98% of the pediatric patients.
- Key abnormalities included hypocitraturia (82.8%), hyperoxaluria (26.4%), hyperuricosuria (32.8%), and hypercalciuria (20.4%).
- Younger children (1-5 years) showed higher rates of hyperuricosuria, hyponatriuria, and hypovolemia compared to older children (11-15 years).
Conclusions:
- Metabolic analysis is highly effective in identifying risk factors in pediatric stone formers.
- Findings support the implementation of targeted metaphylaxis for both treatment and prevention of kidney stones in children.
- Understanding age- and gender-specific risk factors can optimize treatment strategies in pediatric urolithiasis.
Abstract:
The goal of this study was to investigate metabolic risk factors in pediatric stone formers in an emerging economy. A prospective, data collection enrolled 250 children age <1-15 years at our center. Risk factors were evaluated by gender and in age groups <1-5, 6-10 and 11-15 years. Patients were evaluated for demographics, blood and 24 h urine for calcium, magnesium, phosphate, uric acid, electrolytes and additional protein, citrate, ammonia and oxalate in urine. All reported values were two sided and statistical significance was considered at p value ≤0.05. The mean age at diagnosis was 7.50 ± 3.56 years with a male to female ratio of 1.84:1. A family history of urolithiasis was found in 41 (16.4 %), urinary tract infection in 18 (7 %) and chronic diarrhea in 75 (30 %). Hypercalcemia was seen in 37 (14.8 %), hyperuricemia in 23 (9.2 %) and hyperphosphatemia in 6 (2.4 %). Urinary metabolic abnormalities were identified in 248 (98 %) of the cases. Hypocitraturia was found in 207 (82.8 %), hyperoxaluria in 62 (26.4 %), hyperuricosuria in 82 (32.8 %), hypercalciuria in 51 (20.4 %), hyperphosphaturia in 46 (18.4 %), hyperammonuria in 10 (4 %), hypocalciuria in 82 (32.8 %), and hypovolemia in 73 (29.2 %). Risk factors were similar between genders except higher rates of hyponatriuria, hypophosphaturia, and hypocalciuria in females. Hyperuricosuria, hyponatriuria, and hypovolemia were highest in 1-5 years (52, 49, 49 %) as compared to (18, 21, 12 %) those in 11-15 years (p < 0.001), respectively. This study shows that careful metabolic analysis can identify risk factors in 98 % of the children where appropriate metaphylaxis can be undertaken both for treatment and prevention of recurrence.
Related Concept Videos
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Urinary Tract Calculi I: Introduction
Urinary Tract Calculi III: Medical Management
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

